This coordination geometry not only stabilizes the copper ion but also modulates its redox potential, preventing the formation of reactive oxygen species that characterize free copper toxicity
Double anthracycline (mitoxantrone + idarubicin) therapy with cyclosporin a (CSA) to block multidrug resistance (MDR) as salvage therapy for relapsed or refractory acute myelogenous leukemia (R-AML)
By significantly reducing the risk of comorbid conditions like type 2 diabetes and cardiovascular diseases, it enhances overall health outcomes
[1] [2] This low introductory dose is intentional it allows the body to gradually adapt to the drug's pharmacological effects before the dose is escalated
The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea and are typically mild to moderate, often reducing over time with dose escalation protocols
PEAKTOX nutritionists guide you to balance your diet, reducing gastrointestinal side effects and supporting overall health